what is conjunctivitis
What are teh 3 types of conjunctivitis
previlance of viral conjunctivitis
previlance of bacterial conjunctivitis
2nd most common
previlance of allergic conjunctivitis
non-infectious, least frequent
clinical presentation of viral conjunctivites

clinical presentation of bacterial conjunctivitis

clinical presentation of allergic conjunctivitis
Mild to severe ocular itching, redness and watery or mucoid discharge, mild eyelid swelling and bilateral presentation

what are the risk factors for conjunctivities
● Exposure to someone infected with active viral or bacterial conjunctivitis
● Contact lens use, poor contact lens hygiene
● Foreign body exposure
● Use of contaminated cosmetic eye products
● Chronic dry eye or blepharitis
● Use of ophthalmic or other medications that might cause allergic reactions or dry eyes
● Immunosuppression, rheumatological disease, allergic rhinitis
what information to collect for SCHOLAR
HAMS for conjunctivitis
s• S: history of smoking, alcohol use and caffeine use, hobbies, travel, sexual history, use of illicit drugs
Red flags signs and symptoms of conjunctivitis
● Contact lens wearer due to the high risk of corneal ulcer
● Visual loss, blurred vision, halos
● Moderate to severe pain or ocular trauma
● Severe or hyperpurulent discharge or any corneal involvement
● Photophobia or coloured halos around lights
● Irregular pupils- fixed, smaller, larger
● Visible corneal opacity or haze
● Rash +/-blisters around eye or redness at the corneoscleral junction, ciliary flush
● Foreign body sensation
● Severe headache with nausea, vomiting
● Bacterial ophthalmic infections in children
differential diagnosis

what are the goals of therapy
what are the non-pharmacological recommendations for conjunctivitis
pharmacological treatment for Viral conjuncivitis
*decongestants/vasoconstrictors may provide angle closure glaucoma (reserved for occasional short term use)
Drugs used for adjunctive or supportive drug therapties for virual conjunctivities
ocular lubricants
opthalmic vasoconstictior monotherapy
antihistamine/ophthalamis vasoconstictor
describe does/directions, safety and considerations for
ocular lubricant
*treatment of viral conjunctivitis
Dose/directions: 1-2 drops TID to QID
safety: preservative toxicity, filmy/blurry vision
considerations: preferable to use preservative free product to minimize eye irritation
describe does/directions, safety and considerations for
Ophthalmic vasoconstrictor monotherapy
ex: . Naphazoline, oxymetazoline, phenylephrine, tetrahydrozoline
dose/directions: 1-2 drops every 3 to 4 hours or up to QID ≤ 3-4 times per month and ≤ days in a row
safety: Minor stinging on instillation, pupillary dilatation and angle closure glaucoma in predisposed patients
considerations: Ophthalmic vasoconstrictors are meant for occasional and short-term use. Overuse may cause rebound hyperemia
Antihistamine/ophthalmic vasoconstrictor/combinations
Eg. Antazoline/naphazoline Pheniramine/naphazoline
dose/directions: 1-2 drops every 3 to 4 hours or up to QID ≤ 3-4 times per month and ≤ days in a row
safety: Minor stinging on instillation, pupillary dilatation and angle closure glaucoma in predisposed patients
considerations: Ophthalmic vasoconstrictors are meant for occasional and short-term use. Overuse may cause rebound hyperemia
describe pharmacological treatment for bacterial conjunctivitis
-> Polymyxin B/gramicidin combinations
• Rx treatment for moderate infection (copious amounts of discharge and tearing, moderate burning)
-> Erythromycin, trimethoprim/polymyxin B, tobramycin
OTC treatment for bacterial conjunctivitis
polymyxin B gramicidin eye/ear drops
what are the prescription treatments for bacterial conjunctivitis
Fusidic acid 1% viscous eye drops
Trimethoprom/polymyxin 0.3% opthalmic drops
describe directions, safety and considerations of Erthromycin 0.5% ointment
sig: 1 xm 2-6x daily F1W
Antibacterials: chronic use can cause corneal epithelum toxicity, allergy and bacterial resistance
considerations: moderate to severe infection